Loading…
Loading…
ProShares UltraShort Health Care (NYSEARCA:RXD - Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 9,205 shares, a growth of 25.1% from the December 15th total of 7,358 shares. Approximately 7.7% of the shares of the company
Wall Street saw a strong start to August but the rally fizzled in the last couple of weeks, driven by renewed aggressive Fed rate hike speculation.
We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for RXD and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.